Yan‐Ping Mao

11.4k total citations · 1 hit paper
203 papers, 6.4k citations indexed

About

Yan‐Ping Mao is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Yan‐Ping Mao has authored 203 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Otorhinolaryngology, 86 papers in Surgery and 81 papers in Oncology. Recurrent topics in Yan‐Ping Mao's work include Head and Neck Cancer Studies (135 papers), Head and Neck Surgical Oncology (51 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers). Yan‐Ping Mao is often cited by papers focused on Head and Neck Cancer Studies (135 papers), Head and Neck Surgical Oncology (51 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers). Yan‐Ping Mao collaborates with scholars based in China, United States and Canada. Yan‐Ping Mao's co-authors include Jun Ma, Ying Sun, Ling‐Long Tang, Lei Chen, Ai-Hua Lin, Rui Guo, Aihua Lin, Guan‐Qun Zhou, Lizhi Liu and Li-Zhi Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Yan‐Ping Mao

200 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma

2019 241 citations Hao Peng, Di Dong et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Yan‐Ping Mao

Since Specialization

Citations

This map shows the geographic impact of Yan‐Ping Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Ping Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Ping Mao more than expected).

Fields of papers citing papers by Yan‐Ping Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Ping Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Ping Mao. The network helps show where Yan‐Ping Mao may publish in the future.

Co-authorship network of co-authors of Yan‐Ping Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Ping Mao. A scholar is included among the top collaborators of Yan‐Ping Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Ping Mao. Yan‐Ping Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural insights into non-hotspot KRAS mutations and their potential as targets for effective cancer therapies 2024 ·Journal of Biomolecular Structure and Dynamics ·Cong Ding, Gaoyuan Wang, (unknown), Yan‐Ping Mao, Jun Ma	1
2	Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy 2024 ·European Radiology ·Shunxin Wang, Yi Yang, (unknown), (unknown), (unknown), Haojiang Li, (unknown), Wei‐Jie Luo, Yiming Lei, Ying Sun, Jun Ma, Yanfeng Chen, Lizhi Liu, Yan‐Ping Mao	4
3	Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression. 2023 ·PubMed ·Jian Sun, (unknown), (unknown), Yan‐Ping Mao, Wei Yu	6
4	Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study 2022 ·Radiation Oncology ·(unknown), Kai‐Bin Yang, Ying Huang, (unknown), (unknown), Lei Chen, Wen‐Fei Li, Xiaodan Huang, Li Lin, Yu‐Pei Chen, Yan‐Ping Mao, Ling‐Long Tang, Jun Ma	5
5	An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma 2021 ·Cancer Medicine ·Yue Chen, Tianqi Luo, Si‐Si Xu, (unknown), Ying Sun, Li Lin, Yan‐Ping Mao	15
6	Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems 2021 ·Radiotherapy and Oncology ·Yan‐Ping Mao, Shunxin Wang, William M. Lydiatt, Jatin P. Shah, A. Dimitrios Colevas, Anne W.M. Lee, Brian O’Sullivan, Rui Guo, Wei‐Jie Luo, Yu‐Pei Chen, Li Tian, Ling‐Long Tang, Ying Sun, Lizhi Liu, Jian Ren, Jun Ma	41
7	Evolving landscape and academic attitudes toward the controversies of global immuno‐oncology trials 2021 ·International Journal of Cancer ·Cheng Xu, Shu Zhang, Yuan Zhang, Siqi Tang, Xueliang Fang, (unknown), Liang Peng, (unknown), Yan‐Ping Mao, Ling‐Long Tang, Qing Liu, Aihua Lin, Ying Sun, Jun Ma	3
8	Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era 2020 ·Cancer Medicine ·Xing‐Li Yang, Guan‐Qun Zhou, Li Lin, (unknown), Fo‐Ping Chen, Jia‐Wei Lv, Jia Kou, (unknown), Jun Ma, Ying Sun, Yan‐Ping Mao	4
9	Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases 2020 ·Cancer Communications ·Chen‐Fei Wu, Jia‐Wei Lv, Li Lin, Yan‐Ping Mao, Bin Deng, Weihong Zheng, (unknown), Yue Chen, Jia Kou, Fo‐Ping Chen, Xing‐Li Yang, Zi‐Qi Zheng, Zhi‐Xuan Li, Si‐Si Xu, Jun Ma, Ying Sun	12
10	Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis 2020 ·Oral Oncology ·(unknown), Cheng Xu, (unknown), Ling‐Long Tang, Wen-Fei Li, Lei Chen, Yan‐Ping Mao, Rui Guo, Qing Liu, Ying Sun, Jun Ma	14
11	Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology 2020 ·Journal for ImmunoTherapy of Cancer ·Yaqin Wang, Lei Chen, Yan‐Ping Mao, Ying-Qing Li, Wei Jiang, Shuoyu Xu, Yu Zhang, Yu‐Pei Chen, Xiaomin Li, Qing‐Mei He, Shiwei He, Xiaojing Yang, Lei Yuan, Yin Zhao, Jing‐Ping Yun, Na Liu, Ying‐Qin Li, Jun Ma	32
12	Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma breakdown → 2019 ·Clinical Cancer Research ·Hao Peng, Di Dong, (unknown), Lu Li, Ling‐Long Tang, Lei Chen, Wen-Fei Li, Yan‐Ping Mao, Wei Fan, Li-Zhi Liu, Li Tian, Ai-Hua Lin, Ying Sun, Jie Tian, Jun Ma	241
13	Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual 2019 ·Oral Oncology ·Yaqin Wang, Jia-Wei Lv, Ling‐Long Tang, Xiao-Jing Du, Lei Chen, Wen-Fei Li, Xu Liu, Ying Guo, Ai-Hua Lin, Yan‐Ping Mao, Ying Sun, Yu‐Pei Chen, Jun Ma	9
14	Patterns of EBV-positive cervical lymph node involvement in head and neck cancer and implications for the management of nasopharyngeal carcinoma T0 classification 2019 ·Oral Oncology ·Wei‐Jie Luo, Yanfen Feng, Rui Guo, Ling‐Long Tang, Lei Chen, Guan‐Qun Zhou, Wen‐Fei Li, Xu Liu, Ying Sun, Aihua Lin, Jun Ma, Yan‐Ping Mao	16
15	Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort 2018 ·Oral Oncology ·Liang Peng, Cheng Xu, Yu‐Pei Chen, Rui Guo, Yan‐Ping Mao, Ying Sun, Jun Ma, Ling‐Long Tang	15
16	Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era 2017 ·Journal of the National Comprehensive Cancer Network ·Ling‐Long Tang, Yu‐Pei Chen, Yan‐Ping Mao, Zixian Wang, Rui Guo, Lei Chen, Li Tian, Ai-Hua Lin, Li Li, Ying Sun, Jun Ma	139
17	MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma 2013 ·Molecular Cancer ·Na Liu, Ning Jiang, Rui Guo, Wei Jiang, Qing-Mei He, Ya-Fei Xu, Ying-Qin Li, Ling‐Long Tang, Yan‐Ping Mao, Ying Sun, Jun Ma	103
18	Prognostic Impact of Cigarette Smoking on the Survival of Patients with Established Nasopharyngeal Carcinoma 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Pu‐Yun OuYang, Zhen Su, Yan‐Ping Mao, (unknown), Qing Liu, Wuguo Deng, Fang‐Yun Xie	28
19	Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma 2013 ·Chinese Journal of Cancer ·Changjuan Tao, Xu Liu, Ling‐Long Tang, Yan‐Ping Mao, Lei Chen, (unknown), (unknown), Li-Zhi Liu, Rong Zhang, Ai-Hua Lin, Jun Ma, Ying Sun	29
20	Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy 2013 ·Chinese Journal of Cancer ·Changjuan Tao, Xu Liu, Ling‐Long Tang, Yan‐Ping Mao, Lei Chen, (unknown), (unknown), Li-Zhi Liu, Rong Zhang, Ai-Hua Lin, Jun Ma, Ying Sun	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact